Dry powder inhaler delivery of amorphous drug nanoparticles: Effects of the lactose carrier particle shape and size

Powder Technology

Volumn 233, Issue , 2013, Pages 303-311

  Kho, Katherine ^a   Hadinoto, Kunn ^a  

^a Nanyang Technological University   (Singapore)

Author keywords

Aerosolization; Drug nanoparticles; Dry powder inhaler; Lactose carriers; Pollen particles

Indexed keywords

AEROSOLIZATION; AMORPHOUS NANOPARTICLES; CARRIER PARTICLES; CIPROFLOXACIN; DISPERSIBILITIES; DRUG LOADING; DRUG NANOPARTICLES; DRY POWDER INHALER; FINE PARTICLE FRACTIONS; MASS MEDIAN AERODYNAMIC DIAMETERS; MICRO-PARTICLES; POLLEN PARTICLES; POORLY SOLUBLE DRUGS; SIZE RANGES;

BIOCHEMISTRY; EFFICIENCY; NEEDLES; SUGARS;

NANOPARTICLES;

AMORPHOUS DRUG NANOPARTICLE; CIPROFLOXACIN; DRUG CARRIER; LACTOSE; NANOCRYSTAL; NANOPARTICLE; POLYELECTROLYTE; UNCLASSIFIED DRUG;

AEROSOL; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DISPERSION; DRUG FORMULATION; PARTICLE SIZE; POWDER INHALER; SCANNING ELECTRON MICROSCOPY;

EID: 84867796434     PISSN: 00325910     EISSN: 1873328X     Source Type: Journal    
DOI: 10.1016/j.powtec.2012.09.023     Document Type: Article

References (25)

1. Dhumal R.S., Biradar S.V., Yamamura S., Paradkar A.R., York P. Preparation of amorphous cefuroxime axetil nanoparticles by sonoprecipitation for enhancement of bioavailability. European Journal of Pharmaceutics and Biopharmaceutics Sep 2008, 70(1):109-115.
2. Matteucci M.E., Hotze M.A., Johnston K.P., Williams R.O. Drug nanoparticles by antisolvent precipitation: mixing energy versus surfactant stabilization. Langmuir 2006, 22(21):8951-8959. (2006/10/01).
3. Brouwers J., Brewster M.E., Augustijns P. Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability?. Journal of Pharmaceutical Sciences 2009, 98(8):2549-2572.
4. Rabinowitz J.D., Lloyd P.M., Munzar P., Myers D.J., Cross S., Damani R., et al. Ultra-fast absorption of amorphous pure drug aerosols via deep lung inhalation. Journal of Pharmaceutical Sciences Nov 2006, 95(11):2438-2451.
5. Gonda I. Systemic delivery of drugs to humans via inhalation. Journal of Aerosol Medicine-Deposition Clearance and Effects in the Lung 2006, 19(1):47-53. (Spr).
6. Kho K., Cheow W.S., Lie R.H., Hadinoto K. Aqueous re-dispersibility of spray-dried antibiotic-loaded polycaprolactone nanoparticle aggregates for inhaled anti-biofilm therapy. Powder Technology Nov 2010, 203(3):432-439.
7. Beck-Broichsitter M., Schweiger C., Schmehl T., Gessler T., Seeger W., Kissel T. Characterization of novel spray-dried polymeric particles for controlled pulmonary drug delivery. Journal of Controlled Release Mar 2012, 158(2):329-335.
8. Ungaro F., d'Angelo I., Coletta C., Bianca R.D.D., Sorrentino R., Perfetto B., et al. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers. Journal of Controlled Release Jan 2012, 157(1):149-159.
9. Chougule M., Padhi B., Misra A. Nano-liposomal dry powder inhaler of tacrolimus: preparation, characterization, and pulmonary pharmacokinetics. International Journal of Nanomedicine 2007, 2(4):675-688.
10. de Boer A.H., Chan H.K., Price R. A critical view on lactose-based drug formulation and device studies for dry powder inhalation: which are relevant and what interactions to expect?. Advanced Drug Delivery Reviews Mar 2012, 64(3):257-274.
11. Kaialy W., Martin G.P., Larhrib H., Ticehurst M.D., Kolosionek E., Nokhodchi A. The influence of physical properties and morphology of crystallised lactose on delivery of salbutamol sulphate from dry powder inhalers. Colloids and Surfaces. B, Biointerfaces 2012, 89:29-39.
12. Donovan M.J., Smyth H.D.C. Influence of size and surface roughness of large lactose carrier particles in dry powder inhaler formulations. International Journal of Pharmaceutics 2010, 402(1Äì2):1-9.
13. Larhrib H., Martin G.P., Marriott C., Prime D. The influence of carrier and drug morphology on drug delivery from dry powder formulations. International Journal of Pharmaceutics May 2003, 257(1-2):283-296.
14. Dickhoff B.H.J., de Boer A.H., Lambregts D., Frijlink H.W. The effect of carrier surface treatment on drug particle detachment from crystalline carriers in adhesive mixtures for inhalation. International Journal of Pharmaceutics 2006, 327(1Äì2):17-25.
15. Hassan M.S., Lau R. Inhalation performance of pollen-shape carrier in dry powder formulation: effect of size and surface morphology. International Journal of Pharmaceutics Jul 2011, 413(1-2):93-102.
16. Kawashima Y., Serigano T., Hino T., Yamamoto H., Takeuchi H. Effect of surface morphology of carrier lactose on dry powder inhalation property of pranlukast hydrate. International Journal of Pharmaceutics 1998, 172(1-2):179-188.
17. Kaialy W., Alhalaweh A., Velaga S.P., Nokhodchi A. Effect of carrier particle shape on dry powder inhaler performance. International Journal of Pharmaceutics 2011, 421(1):12-23.
18. Hadinoto K., Curtis J.S. Numerical simulation of the Reynolds number effect on gas-phase turbulence modulation. International Journal of Multiphase Flow Feb 2009, 35(2):129-141.
19. Zeng X.M., Martin G.P., Marriott C., Pritchard J. The influence of carrier morphology on drug delivery by dry powder inhalers. International Journal of Pharmaceutics 2000, 200(1):93-106.
20. Larhrib H., Cespi M., Dyas M.A., Roberts M., Ford J. Engineered carrier with a long time of flight (TOF) to improve drug delivery from dry powder inhalation aerosols. Proceedings of Drug Delivery to the Lung XVII; 2006 2006, 304-307. Edinburg, Scotland.
21. Li Q., Rudolph V., Weigl B., Earl A. Interparticle van der Waals force in powder flowability and compactibility. International Journal of Pharmaceutics Aug 2004, 280(1-2):77-93.
22. Samyn J.C., Murthy K.S. Experiments in powder blending and unblending. Journal of Pharmaceutical Sciences 1974, 63(3):370-375.
23. Louey M.D., Van Oort M., Hickey A.J. Standardized entrainment tubes for the evaluation of pharmaceutical dry powder dispersion. Journal of Aerosol Science Nov 2006, 37(11):1520-1531.
24. Zhao H., Le Y., Liu H.Y., Hu T.T., Shen Z.G., Yun J., et al. Preparation of microsized spherical aggregates of ultrafine ciprofloxacin particles for dry powder inhalation (DPI). Powder Technology Aug 2009, 194(1-2):81-86.
25. Gombas A., Szabo-Revesz P., Kata M., Regdon G., Eros I. Quantitative determination of crystallinity of alpha-lactose monohydrate by DSC. Journal of Thermal Analysis and Calorimetry 2002, 68(2):503-510.